PRO/AH/EDR> COVID-19 update (34): vaccine, N-terminal domain, USA ex Brazil, WHO, global

COVID-19 — United States
Abstract
——–
“Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative infection of a global pandemic that has led to more than 2 million deaths worldwide. The Moderna mRNA-1273 vaccine has demonstrated approximately 94% efficacy in a phase 3 study and has been approved under Emergency Use Authorization. The emergence of SARS-CoV-2 variants with mutations in the spike protein, most recently circulating isolates from the United Kingdom (B.1.1.7) and Republic of South